This study assesses comparative resource use for patients given a new diagnosis of nonvalvular atrial fibrillation treated with dabigatran or warfarin in a real-world setting.
Samuel P. Sutherland, BS
Advertisement
Articles by Samuel P. Sutherland, BS
Advertisement
Latest Updated Articles
- Resource Use Among Nonvalvular Atrial Fibrillation Patients
October 18th 2016
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means
2
Subcutaneous Isatuximab On-Body Injector Shows High Reliability, Favorable Safety Across Multiple Myeloma Trials
3
Real-World Use of Talazoparib Plus Enzalutamide and HR Testing Trends in Prostate Cancer
4
Apnimed Submits NDA for AD109 Following Positive Phase 3 Results in Obstructive Sleep Apnea
5